Injectable Poly‐l‐Lactic Acid for Human Immunodeficiency Virus–Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open‐Label Study (FACES)

• Published in: Dermatologic surgery Vol. 38; no. 7pt2; pp. 1193 - 1205
• Main Authors: Bassichis, Benjamin, Blick, Gary, Conant, Marcus, Condoluci, David, Echavez, Michael, Eviatar, Joseph, Gold, Michael H., Hamilton, Tiffani, Hanke, C. William, Humble, Gail, LaMarca, Anthony, Daro‐Kaftan, Elizabeth, Mest, Douglas, Pierone, Gerald
• Format: Journal Article
• Language: English
• Published: United States 01.07.2012
• Subjects: Adipose Tissue - pathology; Adult; Aged; Atrophy; Cosmetic Techniques; Female; HIV Infections - complications; Human immunodeficiency virus; Humans; Immunodeficiency; Injections; Lactic Acid - administration & dosage; lipoatrophy; Male; Middle Aged; Nodules; Patient Satisfaction; Polyesters; Polylactic acid; Polymers - administration & dosage; Sex; Skin; Tea; Tetraethylammonium

Background Studies of injectable poly‐l‐lactic acid (PLLA) in human immunodeficiency virus (HIV)‐associated facial lipoatrophy have predominantly included male Caucasians. Objective To report cumulative year 2 interim study results examining the safety and efficacy of injectable PLLA in subjects wit...